Standard Versus Modified Ipilimumab, in Combination With Nivolumab, in Advanced Renal Cell Carcinoma: A Randomized Phase II Trial (PRISM)Naveen Vasudev, Thomas Powles, Sarah Brown et al.|Journal of Clinical Oncology|2023Cited by 14